Cardiovascular magnetic resonance in light-chain amyloidosis to guide treatment

AIMS: To assess the ability of cardiovascular magnetic resonance (CMR) to (i) measure changes in response to chemotherapy; (ii) assess the correlation between haematological response and changes in extracellular volume (ECV); and (iii) assess the association between changes in ECV and prognosis over...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Naharro, Ana, Patel, Rishi, Kotecha, Tushar, Karia, Nina, Ioannou, Adam, Petrie, Aviva, Chacko, Liza A, Razvi, Yousuf, Ravichandran, Sriram, Brown, James, Law, Steven, Quarta, Cristina, Mahmood, Shameem, Wisniowski, Brendan, Pica, Silvia, Sachchithanantham, Sajitha, Lachmann, Helen J, Moon, James C, Knight, Daniel S, Whelan, Carol, Venneri, Lucia, Xue, Hui, Kellman, Peter, Gillmore, Julian D, Hawkins, Philip N, Wechalekar, Ashutosh D, Fontana, Marianna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Clinical Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712028/
https://www.ncbi.nlm.nih.gov/pubmed/36239754
http://dx.doi.org/10.1093/eurheartj/ehac363

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9712028/
https://www.ncbi.nlm.nih.gov/pubmed/36239754
http://dx.doi.org/10.1093/eurheartj/ehac363

Ejemplares similares